Clinical Trials · NCT02895672

GLP-1/Basal Insulin Combination Therapy

CompletedN/ALiraglutide (Approved)Exenatide (Approved)
Phase
N/A
Recruitment status
Completed
Sponsor
Albany College of Pharmacy and Health Sciences
Enrollment
150
Start date
Aug 2016
Locations
See registry
Primary endpoint
A1C
View Liraglutide compound reference